Methyldopa description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Methyldopa

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

METHYLDOPA DESCRIPTION



Methyldopa




CLINICAL PHARMACOLOGY







Pharmacokinetics and Metabolism




INDICATIONS & USAGE


METHYLDOPA CONTRAINDICATIONS



WARNINGS).


WARNINGS

It is important to recognize that a positive Coombs test, hemolytic anemia, and liver disorders may occur with methyldopa therapy. The rare occurrences of hemolytic anemia or liver disorders could lead to potentially fatal complications unless properly recognized and managed. Read this section carefully to understand these reactions.









PRECAUTIONS

General
WARNINGS).




Laboratory Tests
WARNINGS).

Drug Interactions




CONTRAINDICATIONS.

Drug/Laboratory Test Interactions



Carcinogenesis, Mutagenesis, Impairment of Fertility




Pregnancy

Teratogenic Effects





Nursing Mothers


Pediatric Use
DOSAGE AND ADMINISTRATION).

Geriatric Use
DOSAGE AND ADMINISTRATION).

METHYLDOPA ADVERSE REACTIONS



Cardiovascular:Aggravation of angina pectoris, congestive heart failure, prolonged carotid sinus hypersensitivity, orthostatic hypotension (decrease daily dosage), edema or weight gain, bradycardia.
Digestive:Pancreatitis, colitis, vomiting, diarrhea, sialadenitis, sore ortongue, nausea, constipation, distention, flatus, dryness of mouth.
Endocrine:Hyperprolactinemia.
Hematologic: Bone marrow depression, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia; positive tests for antinuclear antibody, LE cells, and rheumatoid factor, positive Coombs test.
Hepatic:Liver disorders including hepatitis, jaundice, abnormal liver function tests (see WARNINGS).
Hypersensitivity:Myocarditis, pericarditis, vasculitis, lupus-like syndrome, drug-related fever, eosinophilia.
Nervous System/Psychiatric:Parkinsonism, Bellpalsy, decreased mental acuity, involuntary choreoathetotic movements, symptoms of cerebrovascular insufficiency, psychic disturbances including nightmares and reversible mild psychoses or depression, headache, sedation, asthenia or weakness, dizziness, light-headedness, paresthesias.
Metabolic:Rise in BUN.
Musculoskeletal:Arthralgia, with or without joint swelling; myalgia.
Respiratory:Nasal stuffiness.
Skin:Toxic epidermal necrolysis, rash.
Urogenital:Amenorrhea, breast enlargement, gynecomastia, lactation, impotence, decreased libido.

OVERDOSAGE






DOSAGE & ADMINISTRATION

Adults








PRECAUTIONS, Geriatric Use).

PEDIATRIC PATIENTS
PRECAUTIONS, Pediatric Use).

HOW SUPPLIED


STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Methyldopa


Methyldopa

Methyldopa

METHYLDOPA TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-113(NDC:0093-2931)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHYLDOPA METHYLDOPA ANHYDROUS 250 mg

Inactive Ingredients

Ingredient Name Strength
CITRIC ACID MONOHYDRATE
SILICON DIOXIDE
EDETATE DISODIUM
ETHYLCELLULOSES
HYPROMELLOSES
MAGNESIUM STEARATE
METHYLCELLULOSE (400 MPA.S)
POLYETHYLENE GLYCOLS
CALCIUM SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
titanium dioxide
hydroxypropyl cellulose
talc

Product Characteristics

Color Size Imprint Code Shape
white 10 mm N11 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-113-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070098 2012-09-25


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.